Current Ratio in % of Aquestive Therapeutics, Inc. from Q1 2019 to Q3 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Aquestive Therapeutics, Inc. quarterly Current Ratio history and change rate from Q1 2019 to Q3 2025.
  • Aquestive Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 478 %, a 11.9% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Aquestive Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 478 -64.3 -11.9% 30 Sep 2025
Q2 2025 471 +66.5 +16.4% 30 Jun 2025
Q1 2025 571 +332 +139% 31 Mar 2025
Q4 2024 610 +472 +343% 31 Dec 2024
Q3 2024 543 +426 +367% 30 Sep 2024
Q2 2024 405 +301 +289% 30 Jun 2024
Q1 2024 239 +126 +111% 31 Mar 2024
Q4 2023 137 +11.2 +8.87% 31 Dec 2023
Q3 2023 116 -36.3 -23.8% 30 Sep 2023
Q2 2023 104 -78 -42.8% 30 Jun 2023
Q1 2023 113 -89.7 -44.2% 31 Mar 2023
Q4 2022 126 -87.8 -41% 31 Dec 2022
Q3 2022 153 -60.7 -28.4% 30 Sep 2022
Q2 2022 182 -26 -12.5% 30 Jun 2022
Q1 2022 203 -18.5 -8.37% 31 Mar 2022
Q4 2021 214 -31.6 -12.8% 31 Dec 2021
Q3 2021 213 -77.1 -26.5% 30 Sep 2021
Q2 2021 208 -84.4 -28.9% 30 Jun 2021
Q1 2021 221 -28.7 -11.5% 31 Mar 2021
Q4 2020 246 +28.9 +13.3% 31 Dec 2020
Q3 2020 290 +97.1 +50.2% 30 Sep 2020
Q2 2020 292 +65.3 +28.8% 30 Jun 2020
Q1 2020 250 +32 +14.7% 31 Mar 2020
Q4 2019 217 31 Dec 2019
Q3 2019 193 30 Sep 2019
Q2 2019 227 30 Jun 2019
Q1 2019 218 31 Mar 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.